Nanoparticle-Mediated Explosive Anti-PD-L1 Factory Built in Tumor for Advanced Immunotherapy

Scientists presented a novel strategy for priming robust immunotherapy, offering targeted antibody release through laser-assisted photodynamic nanoparticles.